This inventor holds 14 USPTO granted patents. Top assignees: Alfatec-Pharma Gmbh, Alfatec-Pharm Gmbh, Paz Arzneimittelentwicklungsgesellschaft Mbh. Active years: 1993-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993-2002
Title: Jurgen Freidenreich: Innovator in Pharmaceutical Advancements
Introduction
Jurgen Freidenreich, based in Schriesheim, Germany, is an accomplished inventor known for his contributions to the pharmaceutical industry. With a remarkable portfolio of 14 patents, he has pioneered advancements that focus on improving drug delivery systems, particularly for peptide-containing medicaments.
Latest Patents
Among his notable inventions is the "Peroral dosage form for peptide containing medicaments, in particular insulin." This patent introduces a dosage form comprising a matrix of gelatin or a gelatin derivative, designed to deliver peptide pharmaceuticals, such as insulin, effectively in the digestive system. This innovation ensures that the active pharmaceutical ingredient remains intact, circumventing degradation by peptidases in the intestinal tract.
Another significant patent is for "Solid bodies containing active substances and a structure consisting of." This invention focuses on accurately measurable shaped articles like granules or pellets that contain hydrophilic macromolecules and active compounds. The production process described in this patent is economically and ecologically favorable, enhancing bioavailability, shelf life, and tolerability of medications. The utility of these shaped articles extends beyond pharmaceuticals into cosmetics, diagnostics, and dietary healthcare.
Career Highlights
Jurgen Freidenreich has made substantial contributions while working with Alfatec Pharma GmbH and Alfatec-Pharm GmbH. His work there has been instrumental in developing innovative solutions that meet the evolving needs of the healthcare market.
Collaborations
In his career, Freidenreich has collaborated with notable professionals, including Jens-Christian Wunderlich and Ursula Schick. These partnerships have played a crucial role in bringing his innovative ideas to fruition, further enhancing the impact of his work in the industry.
Conclusion
Jurgen Freidenreich's innovative spirit and dedication to pharmaceutical advancements have resulted in impactful patents that address critical needs in drug delivery and efficacy. His contributions continue to shape the landscape of pharmaceutical sciences, making him a notable figure in the field of invention.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile